PAVmed reports Q4 2025 results, strengthens capital structure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 30, 2026 8:01 AM EDTPAVmed strengthened its capital structure and relaunched its medical device portfolio under new leadership
Veris Health advanced strategic partnership with OSU and progressed implantable physiological monitor toward FDA submission
Lucid Diagnostics expanded EsoGuard healthcare system access and clinical evidence base
Conference call and webcast to be held today, March 30, at 8:30 AM... More



